QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-...

 crude-oil-down-2-aspire-biopharma-shares-spike-higher

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 0.2% on Thursday. The Dow trade...

Core News & Articles

Anticipated Upcoming MilestonesSublingual High-dose Aspirin (Lead Program)H2 2025: Request meeting with FDA to discuss 505(b)(2...

Core News & Articles

Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production CapacitySupraNaturals is a lead...

Core News & Articles

Aspire's sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes af...

 aspire-shares-are-trading-higher-monday-whats-going-on

Aspire shares are trading higher Monday after the company announced top-line data from its crossover bioavailability trial.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION